...
首页> 外文期刊>Sensors and Actuators >Effects of prostaglandin E_1 on nitric oxide and oxygen dynamics during rat myocardial ischemia-reperfusion utilizing sol-gel derived microsensors
【24h】

Effects of prostaglandin E_1 on nitric oxide and oxygen dynamics during rat myocardial ischemia-reperfusion utilizing sol-gel derived microsensors

机译:溶胶-凝胶微传感器对前列腺素E_1对大鼠心肌缺血再灌注过程中一氧化氮和氧气动力学的影响

获取原文
获取原文并翻译 | 示例

摘要

Prostaglandin E1 (Alprostadil~®, PGE1) is often used for patients with critical limb ischemia due to its vasodilator and anti-platelet effects. Although PGE1 is considered to have a cardioprotective effect against myocardial ischemia-reperfusion (IR) injury, its mechanism and correlation with nitric oxide (NO) for cardioprotection are not clear. In this study, we used sol-gel-modified electrochemical NO and O_2 microsensors to simultaneously measure the changes in NO level and oxygen tension (pO_2) in the myocardium during myocardial IR that were induced by PGE1 pretreatment. Rat hearts were randomly divided into two groups: a control group (n = 5) and a PGE1 group (n=5, with PGE1 pretreatment). Myocardium that underwent PGE1 pretreatment (26.0±13.1%, p<0.001) demonstrated more highly reduced endogenous NO production during the ischemic period than that of the control group (86.7 ± 18.5%). After the onset of reperfusion, %NO level in the PGE1 group increased to a maximum of 82.0 ± 6.4 but did not exceed the pre-ischemic basal NO level. However, in the control group, the maximum %NO response (164.9 ±41.0) on reperfusion was approximately double that of the PGE1 group (p<0.01, n=5). The restoration value of pO_2 in the PGE1 group significantly increased and was restored to pre-ischemic level (82.2 ± 21.3%); however, the pO_2 of the control group did not increase throughout the reperfusion period (12.3 ±13%, p< 0.001). As a result, we suggest that the cardioprotective effect of PGE1 might be attributed to a reduction in excessive NO production during reperfusion. Therefore, simultaneous and real-time monitoring of NO and pO_2 dynamics in the myocardium would be effective in evaluating the effects of therapeutic treatments such as drug administration. Also, the reduction in excessive NO release during the early reperfusion period might be helpful as a therapeutic strategy to protect the myocardium from IR injury.
机译:前列腺素E1(Alprostadil®,PGE1)由于其血管舒张和抗血小板作用,常用于重症肢体缺血的患者。尽管PGE1被认为具有抗心肌缺血再灌注(IR)损伤的心脏保护作用,但其机制和与一氧化氮(NO)相关的心脏保护作用尚不清楚。在这项研究中,我们使用溶胶-凝胶修饰的电化学NO和O_2微传感器同时测量由PGE1预处理诱导的心肌IR中心肌中NO水平和氧张力(pO_2)的变化。将大鼠心脏随机分为两组:对照组(n = 5)和PGE1组(n = 5,使用PGE1预处理)。经过PGE1预处理的心肌(26.0±13.1%,p <0.001)在缺血期间比对照组(86.7±18.5%)表现出更高的内源性NO生成量降低。再灌注开始后,PGE1组的%NO水平最高增加到82.0±6.4,但未超过缺血前的基础NO水平。然而,在对照组中,对再灌注的最大%NO反应(164.9±41.0)约为PGE1组的两倍(p <0.01,n = 5)。 PGE1组pO_2的恢复值显着增加,恢复至缺血前水平(82.2±21.3%);然而,对照组的pO_2在整个再灌注期间并未增加(12.3±13%,p <0.001)。结果,我们认为PGE1的心脏保护作用可能归因于再灌注期间过量NO生成的减少。因此,同时和实时监测心肌中NO和pO_2的动力学将对评估药物治疗等治疗效果有效。而且,减少早期再灌注期间过量NO的释放可能有助于保护心肌免受IR损伤的治疗策略。

著录项

  • 来源
    《Sensors and Actuators》 |2014年第11期|245-251|共7页
  • 作者单位

    Department of Biomedical Engineering & Healthcare Industry Research Institute, College of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea;

    Department of Surgery, School of Medicine, KyungHee University, Seoul 130-701, Republic of Korea;

    Department of Chemistry, College of Natural Science, Kwangwoon University, Seoul 139-701, Republic of Korea;

    Department of Medical Engineering, Graduate School, Kyung Hee University, Seoul 130-701, Republic of Korea;

    Department of Biomedical Engineering & Healthcare Industry Research Institute, College of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea;

    Department of Chemistry, College of Natural Science, Kwangwoon University, Seoul 139-701, Republic of Korea;

    Department of Biomedical Engineering & Healthcare Industry Research Institute, College of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea, Department of Medical Engineering, Graduate School, Kyung Hee University, Seoul 130-701, Republic of Korea, Department of Biomedical Engineering, College of Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea;

    Department of Biomedical Engineering & Healthcare Industry Research Institute, College of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea, Department of Medical Engineering, Graduate School, Kyung Hee University, Seoul 130-701, Republic of Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Prostaglandin E1; Nitric oxide; Oxygen; Simultaneous monitoring; Myocardial ischemia-reperfusion; Sol-gel-modified microsensors;

    机译:前列腺素E1;一氧化氮;氧;同时监控;心肌缺血再灌注;溶胶凝胶修饰的微传感器;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号